NovoTTF System for Glioblastoma Tumors

NovoTTF system for glioblastoma tumors is capable of giving electric currents to disrupt tumor cells before they divide. FDA is yet to give the final approval for its use on patients with glioblastoma tumors.

U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel is of the opinion that the risks of using the NovoTTF-100A System (NovoTTF) is reduced when it is administered as monotherapy instead of standard medical therapy.

Progression of Cancerous Tumors
A new method of examining cancerous tumors suggests that tumors may not evolve gradually, but rather in a punctuated or staccato-like bursts.

A randomized phase III trial for 237 patients with glioblastoma tumors showed that patients treated with the NovoTTF were benefited with better survival time than patients treated with chemotherapy. NovoTTF treated patients also said that they had better quality of life and lesser side effects compared to those treated with chemo.

Source-Medindia

Inflammation in Pancreatic and Breast Tumors Fueled by Protein
A protein that drives tumor-promoting inflammation in pancreatic and breast tumors has been identified in separate studies published online in the Journal of Experimental Medicine).

New Clues to Origin of Pediatric Brain Tumors Via Gene Fusion Mechanisms
For the first time, scientists have performed a detailed analysis of gene fusions present at high frequency in the most common pediatric brain tumors.

Cancer Tumors Can Be Located in Just Single Session With 'Satnav' Device
A 'satnav' like radiotherapy device promises to help doctors treat patients with tumours almost anywhere in the body in a single session.